In CRC, DCP1A expression is elevated, which is associated with advanced TNM stages, lymph node metastasis and poor prognosis, and overexpression of DCP1A enhances P-body formation (Wu et al., 2018a; Wu et al., 2018b). This evidence concerns the gene DCP1A and metastasis.